Risk of COVID-19 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional DMARDs in Italy

OBJECTIVES: To ascertain if hydroxychloroquine (HCQ)/chloroquine (CLQ) and other conventional disease-modifying anti-rheumatic drugs (cDMARDs) use, and rheumatic diseases per se, may be associated with COVID-19-related risk of hospitalization and mortality. METHODS: This case-control study nested wi...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Rheumatology (Oxford)
Κύριοι συγγραφείς: Alegiani, Stefania Spila, Crisafulli, Salvatore, Rossi, Paolo Giorgi, Mancuso, Pamela, Salvarani, Carlo, Atzeni, Fabiola, Gini, Rosa, Kirchmayer, Ursula, Belleudi, Valeria, Kurotschka, Peter Konstantin, Leoni, Olivia, Ludergnani, Monica, Ferroni, Eliana, Baracco, Susanna, Massari, Marco, Trifirò, Gianluca
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Oxford University Press 2021
Θέματα:
Original Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8083276/
https://ncbi.nlm.nih.gov/pubmed/33856453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keab348
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια